fda glp-1 compounding crackdown news october 2025 The announced plans to take action against non-FDA-approved receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the Despite FDA crackdown, unapproved GLP-1s
Description
Non-GLP-1 weight loss medications offer alternatives for patients who cannot tolerate GLP-1 agents or require different mechanisms of action
There's a fundamental shift underway in the pharmaceutical industry
Support for the Long Haul GLP-1 medications are just one piece of the puzzle
However, as we've seen repeatedly in different studies, the reduction in future medical spending rarely offsets the cost of the medication costs
.png)
If Im hot, Im weak, one MyMSTeam member said
